Publications de Patrizia CARRIERI
Primary tabs
A global action agenda for turning the tide on fatty liver disease.
Hepatology
2023
;
79
:
502 - 523.
A call for mindfulness-based interventions for cannabis-use disorders.
L'Encéphale
2023
;
S0013-7006(23)00118-5.
A global research priority agenda to advance public health responses to fatty liver disease.
Journal of Hepatology
2023
;
79
:
618 - 634.
French general practitioners and medical cannabis: A need for training.
L'Encéphale
2023
;
49
:
537 - 539.
Symptom severity is a major determinant of cannabis‐based products use among people with multiple sclerosis.
Journal of Clinical Nursing
2023
;
32
:
6460 - 6473.
Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial).
JHEP Reports Innovation in Hepatology
2023
;
5
(3)
:
100665.
Negative representations of night-shift work and mental health of public hospital healthcare workers in the COVID-19 era (Aladdin survey).
BMC Health Services Research
2023
;
23
(1)
:
187.
Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER).
Harm Reduction Journal
2022
;
19
(1)
:
2.
Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH).
JHEP Reports Innovation in Hepatology
2022
;
5
(1)
:
100614.
Exploring the medical cannabis prescribing behaviors of French general practitioners.
Drug and Alcohol Review
2022
.
Stigma and care avoidance in people with unhealthy alcohol use: A call for research and action.
Journal of Hepatology
2022
;
77
(4)
:
1221 - 1222.
Author response: Improving patient‐provider communication by reducing stigma associated with liver disease.
Liver International
2022
;
42
(12)
:
2920 - 2920.
Smoking increases the risk of post-acute COVID-19 syndrome: Results from a French community-based survey.
Tobacco Induced Diseases
2022
;
20
:
59.
Medical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine.
Frontiers in Public Health
2022
;
10
:
904291.
Perceived stigma, substance use and self-medication in night-shift healthcare workers: a qualitative study.
BMC Health Services Research
2022
;
22
(1)
:
698.
Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey).
Hepatology Communications
2022
;
6
(5)
:
1005-1015.
https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep4.1879
Impact of the COVID-19 crisis on healthcare workers: The need to address quality of working life issues.
Respirology
2022
;
27
(6)
:
469 - 471.
Peer presence and familiarity as key factors to reduce cocaine intake: An effect mediated by the Subthalamic Nucleus.
Psychopharmacology
2022
;
239
(4)
:
1097-1113.
Sleep quality deterioration in healthcare workers during the COVID-19 pandemic: the role of work-related factors and mental health.
European Review for Medical and Pharmacological Sciences
2022
;
26
(8)
:
2648-2650.
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
Journal of Hepatology
2022
;
76
:
771-780.
Examining the Relationships between Mindfulness and Tobacco Craving Factors.
Substance Use and Misuse
2022
;
57
(4)
:
656-659.
HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).
AIDS Research and Therapy
2022
;
19
(1)
Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes.
Liver International
2022
;
42
(5)
:
984 - 994.
Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort).
Clinical Nutrition
2022
;
41
(3)
:
610-619.
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.
PLoS ONE
2022
;
17
(3)
:
e0261069.
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.
The Lancet
2022
;
399
(10319)
:
61-116.
Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors.
JHEP Reports Innovation in Hepatology
2022
;
4
(6)
:
100481.
A syndemic examination of injecting drug use, incarceration and multiple drug-related harms in French opioid users.
International Journal of Prisoner Health
2021
;
ahead-of-print.
Sibling status, home birth, tattoos and stitches are risk factors for chronic hepatitis B virus infection in Senegalese children: A cross‐sectional survey.
Journal of Viral Hepatitis
2021
;
28
(11)
:
1515-1525.
https://onlinelibrary.wiley.com/doi/abs/10.1111/jvh.13589
Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users.
Journal of Cannabis Research
2021
;
3
(1)
:
46.
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort).
Liver International
2021
;
Online ahead of print.
Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH).
Journal of Viral Hepatitis
2021
;
28
(11)
:
1665 - 1667.
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV.
Nature Communications
2021
;
12
(1)
:
4450.
A Twitter discourse analysis of negative feelings and stigma related to NAFLD, NASH and obesity.
Liver International
2021
;
Online ahead of print.
European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
JHEP Reports Innovation in Hepatology
2021
;
3
(2)
:
100234.
A two-component intervention to improve hand hygiene practices and promote alcohol-based hand rub use among people who inject drugs: a mixed-methods evaluation.
BMC Infectious Diseases
2021
;
21
(1)
:
211.
Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France.
Harm Reduction Journal
2021
;
18
(1)
:
11.
Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study.
International Journal of Drug Policy
2021
;
87
:
102992.
Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play.
Seminars in Liver Disease
2021
;
41
(2)
:
109-116.
Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH).
Journal of Viral Hepatitis
2020
;
27
(12)
:
1462-1472.
Risk of Severe Bacterial Infection in People Living Human Immunodeficiency Virus Infection in the Combined Antiretroviral Therapy Era.
Journal of Infectious Diseases
2020
;
222
(5)
:
765-776.
“Everybody living with a chronic disease is entitled to be cured”: Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
International Journal of Drug Policy
2020
;
81
:
102766.
Alcohol Use Patterns and Liver Outcomes: Is There Really a Difference Between Drinking Beer and Drinking Wine?
Clinical Gastroenterology and Hepatology
2020
;
18
(7)
:
1650-1651.
Application of Functional Data Analysis to Identify Patterns of Malaria Incidence, to Guide Targeted Control Strategies.
International Journal of Environmental Research and Public Health
2020
;
17
(11)
:
4168.
https://www.mdpi.com/1660-4601/17/11/4168
HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort).
AIDS and Behavior
2020
;
24
(4)
:
1069-1084.
Correlates of Self-Reported Cotton Fever Experience among People Who Inject Opioids.
Substance Use and Misuse
2020
;
55
(6)
:
1021-1027.
Screening and care for alcohol use disorder in France: expectations, barriers and levers using a mixed-methods approach.
BMC Public Health
2020
;
20
(1)
:
358.
Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).
Journal of Hepatology
2020
;
72
(3)
:
588-591.
Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort.
Clinical Infectious Diseases
2020
;
ciaa117
:
Online ahead of print.
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
BMC Infectious Diseases
2020
;
20
(1)
:
49.
Population attributable fractions of mortality in people living with HIV: roles of delayed antiretroviral therapy, hepatitis coinfections and social factors.
AIDS. Official journal of the international AIDS Society
2020
;
34
(12)
:
1843-1854.
Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit.
European Journal of Gastroenterology & Hepatology
2020
;
1.
Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS-FANTASIO study).
Addiction
2019
;
115
(3)
:
573-582.
France removes hepatitis C treatment prescriber restrictions—But what is the impact of the delay for key populations?
Liver International
2019
;
39
(12)
:
2418-2419.
Prevention and care of hepatitis B in the rural region of Fatick in Senegal : a healthcare workers’ perspective using a mixed methods approach.
BMC Health Services Research
2019
;
19
(1)
Methadone in primary care in France: Using evidence for action against hepatitis C.
International Journal of Drug Policy
2019
;
71
:
91-92.
Factors associated with virological rebound in HIV-positive sub-Saharan migrants living in France after traveling back to their native country -ANRS-VIHVO 2006-2009 study.
Journal of Immigrant and Minority Health
2019
.
No influence of cannabis use on liver stiffness in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study).
European Journal of Gastroenterology & Hepatology
2019
;
31
(2)
:
274-276.
Therapeutic prospects of cannabidiol for alcohol use disorder and alcohol-related damages on the liver and the brain.
Frontiers in Pharmacology
2019
;
10
:
627.
Interventions to address substance use and sexual risk among gay, bisexual and other men who have sex with men who use methamphetamine: A systematic review.
Drug and Alcohol Dependence
2019
;
194
:
410-429.
Letter to the Editor: Patient-Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use.
Hepatology
2019
;
70
(1)
:
443-444.
Changes in supervised drug-injecting practices following a community-based educational intervention: A longitudinal analysis.
Drug and Alcohol Dependence
2018
;
192
:
1 - 7.
Wine Consumption and Lower Risk of Advanced Liver Fibrosis: A True Effect or Unmeasured Confounding? A Longitudinal Analysis (ANRS CO13 HEPAVIH Cohort).
The American Journal of Gastroenterology
2018
;
113
(11)
:
1729-1732.
Barriers and levers in screening and care for alcohol use disorders among French general practitioners: results from a computer-assisted telephone interview-based survey.
Alcoholism Treatment Quarterly
2018
;
37
(2)
:
207-224.
Profile, risk practices and needs of people who inject morphine sulfate: Results from the ANRS-AERLI study.
International Journal of Drug Policy
2018
;
59
:
3 - 9.
Clinical Features and Complications of Coxiella burnetii Infections From the French National Reference Center for Q Fever.
JAMA Network Open
2018
;
1
(4)
:
e181580.
Posttraumatic Stress Disorder as a Significant Correlate of Voluntary Antiretroviral Treatment Interruption in Adult HIV-Infected Patients Followed up in French Hospitals.
Journal of Clinical Psychiatry
2018
;
79
(3)
The need for patient-tailored dosing of baclofen in future clinical trials ☆.
European Neuropsychopharmacology
2018
;
28
(5)
:
656-657.
Reply to: “Coffee consumption and decreased all-cause mortality – What is the true estimate of effect?”.
Journal of Hepatology
2018
;
68
(5)
:
1106.
Gender, Alcohol Use, and Fibrosis in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Individuals.
Clinical Infectious Diseases
2018
;
66
(6)
:
983 - 984.
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients.
World journal of hepatology
2018
;
10
(11)
:
856-866.
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe.
Journal of Hepatology
2018
;
68
(3)
:
402-411.
Hepatitis C virus infection and hospital-related outcomes: a systematic review protocol.
BMJ Open
2018
;
8
(6)
:
e021118.
Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
2018
;
16
(5)
:
377-380.
Factors associated with perceived loss of libido in people who inject opioids: Results from a community-based survey in France.
Drug and Alcohol Dependence
2018
;
190
:
121-127.
Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits.
International Journal of Drug Policy
2018
;
62
:
24-29.
Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).
The Patient - Patient-Centered Outcomes Research
2017
;
10
(5)
:
605 - 614.
Role of community-based research in advocating HCV prevention and care.
Journal of the International AIDS Society
2017
;
20
(2)
:
e25005.
Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).
Digestive Diseases and Sciences
2017
;
62
(10)
:
2943 - 2944.
Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.
Addiction
2017
;
112
(9)
:
1669-1679.
Thrombosis and antiphospholipid antibody syndrome during acute Q fever.
Medicine
2017
;
96
(29)
:
e7578.
Pain in methadone patients: Time to address undertreatment and suicide risk (ANRS-Methaville trial).
PLoS ONE
2017
;
12
(5)
:
e0176288.
No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).
Drug and Alcohol Review
2017
;
36
(2)
:
227-238.
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT).
Clinics and Research in Hepatology and Gastroenterology
2017
;
41
(1)
:
56 - 65.
Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial).
International Journal of Drug Policy
2017
;
39
:
86-91.
The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients.
Journal of Hepatology
2017
;
68
:
840–866.
Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France.
Substance Abuse Treatment, Prevention, and Policy
2016
;
12
(1)
:
46.
Factors Associated with HIV Status Disclosure in HIV-Infected Sub-Saharan Migrants Living in France and Successfully Treated with Antiretroviral Therapy: Results from the ANRS-VIHVO Study.
Journal of Immigrant and Minority Health
2016
;
[Epub ahead of print].
Antiphospholipid Antibody Syndrome With Valvular Vegetations in Acute Q Fever.
Clinical Infectious Diseases
2016
;
537-44.
Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).
Harm Reduction Journal
2015
;
13
(1)
:
12.
Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern.
BMC Public Health
2015
;
15
(1)
:
1093.
Suicidal risk among patients enrolled in methadone maintenance treatment: HCV status and implications for suicide prevention (ANRS Methaville).
Comprehensive Psychiatry
2015
;
62
:
123-131.
Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy (ART): the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.
Antiviral Therapy
2015
;
20
(7)
:
763--772.
Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville).
PLoS ONE
2014
;
9
(11)
:
112328 - 112328.
Predictors of non-prescribed opioid use after one year of methadone treatment: An attributable-risk approach (ANRS-Methaville trial).
Drug and Alcohol Dependence
2014
;
135
:
1-8.
Impact of HCV treatment and depressive symptoms on adherence to HAART among coinfected HIV-HCV patients: results from the ANRS-CO13-HEPAVIH cohort.
Antiviral Therapy
2014
;
19
(2)
:
171-8.
De jure decriminalisation of cannabis use matters: some recent trends from France.
International Journal of Drug Policy
2013
;
epub ahead of print.
Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial.
BMC Public Health
2012
;
12
(1)
:
488.
Limited access to HIV prevention in French prisons (Anrs-Pri2de): implications for public health and drug policy.
BMC Public Health
2011
;
11
(1)
:
400.
Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach.
Harm Reduction Journal
2011
;
8
(1)
:
31.
Quality of life assessment in HIV clinical research in resource-limited settings: better late than never.
Tropical Medicine and International Health
2010
;
15
(9)
:
1008-1010.
Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116).
AIDS Care
2010
;
22
(04)
:
441-451.
Réduction des risques infectieux Chez les usagers de drogues.
2010
;
Les éditions Inserm, ISSN 1264-1782.
Psychosocial correlates of inconsistent condom use among HIVinfected patients enrolled in a structured ART interruptions trial in Coˆ te d’Ivoire: results from the TRIVACAN trial (ANRS 1269).
Tropical Medicine and International Health
2010
.
Impaired Anger Control as an Underappreciated Side Effect of Treatments for Chronic HCV Infection in HIV-HCV Coinfected Patients.
Journal of Clinical Gastroenterology
2008
;
42
:
92 - 96.
Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.
Antiviral Therapy
2008
;
13
(5)
:
697-703.
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
International Journal of Drug Policy
2007
;
18
(4)
:
262-70.
Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8).
International Journal of Drug Policy
2007
;
18
(4)
:
288-95.
Do migrants overreport adherence to highly active antiretroviral therapy?: results from the French VESPA (ANRS-EN12) National Survey.
Journal of Acquired Immune Deficiency Syndromes - JAIDS
2006
;
42
(5)
:
646-7.